DKA Knowledge Challenge!

Obesity & Type 2 Diabetes: An Expert Discussion

Your daily dose of the clinical news you may have missed.

GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.

What is Driving Type 2 Diabetes in the US?

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds

Type 2 diabetes and its high and rising rates in the US are the result of a perfect storm of converging systemic, behavioral, environmental, and economic factors.

New Guidelines Recommend Preconception Screening in Diabetes: Daily Dose

ENDO 2025. People with inconsistent access to GLP-1 medications still achieved clinically significant weight loss when therapy was combined with lifestyle changes and coaching.

Related Content

Obesity & Type 2 Diabetes: An Expert Discussion

Your daily dose of the clinical news you may have missed.

GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.

What is Driving Type 2 Diabetes in the US?

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds

Type 2 diabetes and its high and rising rates in the US are the result of a perfect storm of converging systemic, behavioral, environmental, and economic factors.